Literature DB >> 9460080

Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-kappa B-dependent transcriptional activation of Nos2.

G N Welch1, G R Upchurch, R S Farivar, A Pigazzi, K Vu, P Brecher, J F Keaney, J Loscalzo.   

Abstract

Increased plasma levels of homocysteine are an independent risk factor for atherothrombosis. While the endothelial cytotoxicity of homocysteine has been attributed to oxidative stress associated with the reactivity of the thiol group, the oxidative effect of homocysteine on vascular smooth-muscle cells has not been investigated. Recent evidence suggests that expression of inducible nitric oxide synthase (iNOS), or Nos2 gene product, in vascular smooth-muscle cells may, in part, promote atherosclerosis by increasing local oxidative stress. We therefore hypothesized that homocysteine contributes to atherosclerosis by affecting cytokine-induced production of nitric oxide (NO) by vascular smooth-muscle cells. Confluent rat aortic smooth-muscle cells were exposed to a range of concentrations of homocysteine for 4 hr, then were treated with interferon-gamma, interleukin-1 beta, and lipopolysaccharide to induce iNOS. Media NOx content (nitrite plus S-nitrosothiol) was measured over 24 hr using the Saville reaction. As compared to controls, 5, 50, and 500 microM homocysteine produced a dose-dependent increase in media NOx content, an effect that was primarily a consequence of increased S-nitrosothiol production. iNOS enzyme activity and iNOS protein levels were increased significantly in the homocysteine-treated cells as compared with controls. Northern analysis showed that homocysteine treatment increased steady-state Nos2 mRNA levels by 61% at 6 hr as compared with controls, an effect that was not caused by changes in message stability. By electrophoretic mobility shift assay, homocysteine activated NF-kappa B and also potentiated cytokine activation of NF-kappa B. These data demonstrate that exposure of vascular smooth-muscle cells to pathophysiologically relevant concentrations of homocysteine prior to cytokine stimulation leads both to an increase in NO production and to an NF-kappa B-mediated increase in Nos2 transcription. Upregulation of Nos2 may contribute to the inflammatory response that characterizes early atherogenesis and may, in part, account for the adverse vascular effects of hyperhomocysteinemia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9460080

Source DB:  PubMed          Journal:  Proc Assoc Am Physicians        ISSN: 1081-650X


  20 in total

1.  Hyperhomocysteinemia decreases intestinal motility leading to constipation.

Authors:  S Givvimani; C Munjal; N Narayanan; F Aqil; G Tyagi; N Metreveli; S C Tyagi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-17       Impact factor: 4.052

Review 2.  Arrhythmia and neuronal/endothelial myocyte uncoupling in hyperhomocysteinemia.

Authors:  Dorothea Rosenberger; Karni S Moshal; Ganesh K Kartha; Neetu Tyagi; Utpal Sen; David Lominadze; Claudio Maldonado; Andrew M Roberts; Suresh C Tyagi
Journal:  Arch Physiol Biochem       Date:  2006 Oct-Dec       Impact factor: 4.076

3.  Acute hyperhomocysteinemia alters the coagulation system and oxidative status in the blood of rats.

Authors:  Aline A da Cunha; Emilene Scherer; Maira J da Cunha; Felipe Schmitz; Fernanda R Machado; Daniela D Lima; Débora Delwing; Angela T S Wyse
Journal:  Mol Cell Biochem       Date:  2011-09-23       Impact factor: 3.396

4.  Homocysteine augments cytokine-induced chemokine expression in human vascular smooth muscle cells: implications for atherogenesis.

Authors:  A Desai; H A Lankford; J S Warren
Journal:  Inflammation       Date:  2001-06       Impact factor: 4.092

5.  Nitrative stress in cerebral endothelium is mediated by mGluR5 in hyperhomocysteinemia.

Authors:  Jamie N Mayo; Richard S Beard; Tulin O Price; Cheng-Hung Chen; Michelle A Erickson; Nuran Ercal; William A Banks; Shawn E Bearden
Journal:  J Cereb Blood Flow Metab       Date:  2011-12-21       Impact factor: 6.200

Review 6.  Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets.

Authors:  Yi Fu; Xian Wang; Wei Kong
Journal:  Br J Pharmacol       Date:  2017-09-22       Impact factor: 8.739

7.  Neural tube defects and maternal biomarkers of folate, homocysteine, and glutathione metabolism.

Authors:  Weizhi Zhao; Bridget S Mosley; Mario A Cleves; Stepan Melnyk; S Jill James; Charlotte A Hobbs
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-04

8.  Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model.

Authors:  M A Hofmann; E Lalla; Y Lu; M R Gleason; B M Wolf; N Tanji; L J Ferran; B Kohl; V Rao; W Kisiel; D M Stern; A M Schmidt
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

9.  Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells.

Authors:  Bradley A Maron; Ying-Yi Zhang; Diane E Handy; Annie Beuve; Shiow-Shih Tang; Joseph Loscalzo; Jane A Leopold
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

10.  Impaired nitric oxide-mediated flow-induced coronary dilation in hyperhomocysteinemia: morphological and functional evidence for increased peroxynitrite formation.

Authors:  Zoltan Ungvari; Anna Csiszar; Zsolt Bagi; Akos Koller
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.